Press Releases


July 13, 2021

Notal Vision announces publication of first prospective longitudinal pilot study of daily self-imaging with patient-operated Home OCT in wet AMD patients

June 1, 2021

Notal Vision raises up to $60 million to support development of its Home OCT technology and commercial growth of its ForeseeHome AMD Monitoring Program

April 6, 2021

ForeseeHome AMD home monitoring real-world data analysis demonstrates substantial benefit for patients’ vision

February 23, 2021

AsclepiX Therapeutics partners with Notal Vision on Home OCT remote monitoring in DME and AMD clinical trials

January 12, 2021

Notal Vision Launches First U.S. Home OCT Longitudinal Study with Patient Self-operated Device

Media enquiries? Reach out to our Media Contact